• Fri, May 11, 2018

by: WOPRAI

Andrew Terrell Initiated (TCBK) at Buy and Held Target at $43 on, May 11th, 2018

by: WOPRAI

Peter Arment Downgraded (TGI) to Hold on, May 11th, 2018

by: WOPRAI

Victor Anthony Downgraded (YELP) to Hold on, May 11th, 2018

by: WOPRAI

Paul Bieber Maintained (YELP) at Buy with Increased Target to $60 on, May 11th, 2018

by: WOPRAI

Andreas Bokkenheuser Maintained (X) at Strong Sell with Decreased Target to $28 on, May 11th, 2018

by: WOPRAI

Raghuram Selvaraju Initiated (SPRO) at Strong Buy and Held Target at $28 on, May 11th, 2018

by: WOPRAI

Gena Wang Upgraded (SRPT) to Buy on, May 11th, 2018

by: WOPRAI

Jen Redding Initiated (ANF) at Hold and Held Target at $25 on, May 11th, 2018

by: WOPRAI

Jason Gerberry Initiated (ALKS) at Strong Buy and Held Target at $56 on, May 11th, 2018

by: WOPRAI

Keith Horowitz Upgraded (USB) to Strong Buy on, May 11th, 2018

by: WOPRAI

Jen Redding Initiated (AEO) at Buy and Held Target at $25 on, May 11th, 2018

by: WOPRAI

Geoff Meacham Upgraded (ZYME) to Hold on, May 11th, 2018

by: WOPRAI

Jen Redding Initiated (ZUMZ) at Hold and Held Target at $24 on, May 11th, 2018

by: WOPRAI

Jason McCarthy Maintained (BLFS) at Strong Buy with Increased Target to $12 on, May 11th, 2018

by: WOPRAI

John Egbert Maintained (TTD) at Strong Buy with Increased Target to $7.5 on, May 11th, 2018

by: WOPRAI

Phillip Huang Maintained (TU) at Buy and Held Target at $21 on, May 11th, 2018

by: WOPRAI

Philip Cusick Upgraded (VZ) to Buy on, May 11th, 2018

by: WOPRAI

David Nierengarten Upgraded (VYGR) to Buy on, May 11th, 2018

  • Mon, May 14, 2018

by: WOPRAI

Kevin Hocevar Downgraded (BECN) to Hold on, May 14th, 2018

by: WOPRAI

Ross Smotrich Maintained (CBRE) at Buy with Increased Target to $58 on, May 14th, 2018

by: WOPRAI

Tore Svanberg Downgraded (AOSL) to Strong Sell on, May 14th, 2018

by: WOPRAI

Ken Hoexter Upgraded (UPS) to Strong Buy on, May 14th, 2018

by: WOPRAI

Matthew Niknam Downgraded (UNIT) to Hold on, May 14th, 2018

by: WOPRAI

Paul Coster Downgraded (XRX) to Hold on, May 14th, 2018

by: WOPRAI

Matt Reustle Upgraded (CSX) to Hold on, May 14th, 2018

by: WOPRAI

Rod Hall Initiated (WDC) at Buy and Held Target at $120 on, May 14th, 2018

by: WOPRAI

Saree Boroditsky Upgraded (WAB) to Strong Buy on, May 14th, 2018

by: WOPRAI

Manav Patnaik Maintained (TRI) at Hold with Decreased Target to $41 on, May 14th, 2018

by: WOPRAI

Gary Bisbee Maintained (TRI) at Hold with Decreased Target to $44 on, May 14th, 2018

by: WOPRAI

Aravinda Galappatthige Upgraded (TRI) to Strong Buy on, May 14th, 2018

  • Tue, May 15, 2018

by: WOPRAI

Krish Sankar Initiated (AMAT) at Hold and Held Target at $60 on, May 15th, 2018

by: WOPRAI

Krish Sankar Initiated (ASML) at Hold on, May 15th, 2018

by: WOPRAI

Krish Sankar Initiated (TER) at Hold and Held Target at $40 on, May 15th, 2018

by: WOPRAI

David Anderson Maintained (WHD) at Buy with Increased Target to $36 on, May 15th, 2018

by: WOPRAI

Rupesh Parikh Upgraded (ULTA) to Buy on, May 15th, 2018

by: WOPRAI

Ebrahim Poonawala Downgraded (CBSH) to Sell on, May 15th, 2018

by: WOPRAI

Krish Sankar Initiated (AEIS) at Buy and Held Target at $78 on, May 15th, 2018

by: WOPRAI

John Glass Upgraded (USFD) to Buy on, May 15th, 2018

by: WOPRAI

Peter Winter Initiated (ZION) at Hold and Held Target at $62 on, May 15th, 2018

by: WOPRAI

Doug Schenkel Upgraded (A) to Buy on, May 15th, 2018

  • Wed, May 16, 2018

by: WOPRAI

Hans Chung Downgraded (VIPS) to Hold on, May 16th, 2018

by: WOPRAI

John Choi Downgraded (VIPS) to Hold on, May 16th, 2018

by: WOPRAI

Roxanne Meyer Upgraded (URBN) to Hold on, May 16th, 2018

by: WOPRAI

Julien Dumoulin-Smith Downgraded (AES) to Hold and Decreased Target to $12 on, May 16th, 2018

by: WOPRAI

Navann Ty Upgraded (ALKS) to Strong Buy on, May 16th, 2018

by: WOPRAI

Steven Cahall Initiated (SPOT) at Hold and Held Target at $150 on, May 16th, 2018

by: WOPRAI

Michelle Gilson Initiated (BMRN) at Strong Buy and Held Target at $101 on, May 16th, 2018

by: WOPRAI

Brian Bedell Upgraded (TROW) to Strong Buy on, May 16th, 2018

Gena Wang Upgraded (SRPT) to Buy on, May 11th, 2018

Gena Wang of Barclays, Upgraded "Sarepta Therapeutics, Inc." (SRPT) to Buy on, May 11th, 2018.

Gena has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Hartaj Singh of "Oppenheimer" Downgraded from Buy to Hold on, Friday, May 4th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $91 on, Friday, May 4th, 2018


These are the ratings of the 4 analyists that currently disagree with Gena

  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $92 on, Friday, May 4th, 2018
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $95 on, Wednesday, March 14th, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $92 on, Tuesday, March 13th, 2018
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $92 on, Monday, March 12th, 2018